Curis Inc. (CRIS) is up on buy-out rumors: We say Hold!
Today's Financial News - Posted August 28, 2009
TFN Hot Stock Confidential pick Curis Inc. (NASDAQ:CRIS) soared past our initial profit target today. What’s a man (or woman) to do about it?
by Laura Cadden
Baltimore, MD — TFN: Rumors of a buyout by Roche Holding Ltd. (OTC:RHHBY) (or better, Roche’s Genentech division) have sent the share price of Curis Inc. (NASDAQ:CRIS) up over our 40% targeted gains, from our latest Hot Stock Confidential entry price of $1.52. The stock traded at up to $2.17 during today’s trading activity… just 7 cents away from its 52-week high.
Obviously plenty of people bought the rumor…
Sell the news?
You could cash in your shares (as J. Christoph Amberger — self-confessed glass-half-empty man that he is! — says he’d do). But what if the rumors are true (says I)? Attacking diseases by using technology that targets signaling pathways is a considered a viable new direction for treatments.
And Curis has already collaborated extensively with Genentech… the same Genentech that merged with Roche this past spring.
The choice is, of course, yours… but that relationship is leading me to believe that the buyout story could become a reality.
I recommend you exercise patience and hold on to your shares of Curis Inc. (NASDAQ:CRIS) — for now!
Next Article: Silver prices up, so are HSC miners Coeur d’Alene Mines (CDE) and Silver Wheaton Corp. (SLW)
Be the first to leave a reply.
Your comments are welcome

